GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH
Background & Aims: Steatotic liver disease can lead to the development of metabolic dysfunction-associated steatohepatitis (MASH), the prevalence of which is rapidly increasing, intensifying the need to find an effective treatment. GTX-11 is a first-in-class drug with anti-inflammatory and antif...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2025-10-01
|
| Schriftenreihe: | JHEP Reports |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2589555925001752 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|